Huimei Capital
Asia, Beijing, China, Beijing'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
Huimei Capital primarily seeks investment in the medical and healthcare ecosystem.
Investor Profile
Huimei Capital has backed more than 7 startups, with 1 new investments in the last 12 months alone. The firm has led 2 rounds, about 29% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series B, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, China.
- Strong thematic focus on Biotechnology, Medical, Health Care.
- Led 1 rounds in the past year.
Stage Focus
- Series C (29%)
- Series B (29%)
- Series Unknown (14%)
- Series D (14%)
- Series A (14%)
Country Focus
- United States (57%)
- China (43%)
Industry Focus
- Biotechnology
- Medical
- Health Care
- Medical Device
- Pharmaceutical
- Biopharma
- Therapeutics
- Genetics
- Life Science
- Manufacturing
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
